Cargando…

Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review

OBJECTIVE: The aim of the study was to examine whether high-grade cervical intraepithelial neoplasia (CIN) was more closely associated with human papillomavirus (HPV) same-genotype persistence (SGTP) versus clearance of prior infection with a subsequent infection by a new genotype (genotype switch [...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonde, Jesper, Bottari, Fabio, Iacobone, Anna D., Cocuzza, Clementina E., Sandri, Maria-Teresa, Bogliatto, Fabrizio, Khan, Khalid S., Ejegod, Ditte M., Gary, Devin S., Andrews, Jeffrey C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Screening and Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748037/ https://www.ncbi.nlm.nih.gov/pubmed/33105450 http://dx.doi.org/10.1097/LGT.0000000000000573

Ejemplares similares

Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Systematic Review
por: Bottari, Fabio, et al.
Publicado: (2019)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Human Papillomavirus Same Genotype Persistence and Risk of Cervical Intraepithelial Neoplasia2+ Recurrence
por: Iacobone, Anna Daniela, et al.
Publicado: (2021)

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
por: Bonde, Jesper, et al.
Publicado: (2019)

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
por: Rebolj, Matejka, et al.
Publicado: (2016)

Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review
por: Bonde, Jesper H., et al.
Publicado: (2019)

Cervical Screening Practices and Outcomes for Young Women in Response to Changed Guidelines in Calgary, Canada, 2007–2016
por: Sayed, Sayeeda Amber, et al.
Publicado: (2020)

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
por: Bonde, Jesper, et al.
Publicado: (2014)

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study
por: Ejegod, Ditte Møller, et al.
Publicado: (2015)

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples
por: Ejegod, Ditte Møller, et al.
Publicado: (2016)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
por: Rebolj, Matejka, et al.
Publicado: (2014)

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
por: Preisler, Sarah, et al.
Publicado: (2016)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

Screening for intimate partner violence during pregnancy: a test accuracy study
por: Zapata-Calvente, Antonella Ludmila, et al.
Publicado: (2022)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Human papillomavirus self‐sampling for screening nonattenders: Opt‐in pilot implementation with electronic communication platforms
por: Lam, Janni Uyen Hoa, et al.
Publicado: (2017)

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
por: Bhatia, Ramya, et al.
Publicado: (2023)

Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing
por: Kenna, Kevin P, et al.
Publicado: (2013)

Canadian Open Genetics Repository (COGR): a unified clinical genomics database as a community resource for standardising and sharing genetic interpretations
por: Lerner-Ellis, Jordan, et al.
Publicado: (2015)

Can a print‐based intervention increase screening for first degree relatives of people with colorectal cancer? A randomised controlled trial
por: Carey, Mariko, et al.
Publicado: (2016)

Risk category system to identify pituitary adenoma patients with AIP mutations
por: Caimari, Francisca, et al.
Publicado: (2018)

Developing better strategies for school eye health screening in India
por: Reddy, Priya Adhisesha, et al.
Publicado: (2017)

Screening for ROP
por: Quinn, Graham, et al.
Publicado: (2017)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

A systematic review of health promotion interventions to increase breast cancer screening uptake: from the last 12 years
por: Agide, Feleke Doyore, et al.
Publicado: (2018)

Moving towards an organized cervical cancer screening: costs and impact
por: Diaz, Mireia, et al.
Publicado: (2018)

A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy
por: Ishii, Atsushi, et al.
Publicado: (2017)

Effects of screening and universal healthcare on long-term colorectal cancer mortality
por: Lee, Yi-Chia, et al.
Publicado: (2019)

Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England
por: He, Emily, et al.
Publicado: (2019)

Number of prior negative screening outcomes does not influence future risk of breast cancer
por: Lilleborge, Marie, et al.
Publicado: (2020)

Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting
por: Bao, Minghui, et al.
Publicado: (2020)

Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data
por: Hüsing, Anika, et al.
Publicado: (2020)

Screening for caregiver psychosocial risk in children with medical complexity: a cross-sectional study
por: Verma, Rahul, et al.
Publicado: (2020)

Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors
por: Lebrett, Mikey B, et al.
Publicado: (2021)

Validity of self-reported mammography uptake in the Belgian health interview survey: selection and reporting bias
por: Berete, Finaba, et al.
Publicado: (2020)

Costs and effects of conventional vision screening and photoscreening in the Dutch preventive child health care system
por: Van der Ploeg, Catharina P B, et al.
Publicado: (2020)

Quantitative Checklist for Autism in Toddlers (Q-CHAT). A population screening study with follow-up: the case for multiple time-point screening for autism
por: Allison, Carrie, et al.
Publicado: (2021)

Universal language development screening: comparative performance of two questionnaires
por: Wilson, Philip, et al.
Publicado: (2022)

Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study
por: Sanin, Veronika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uueas1tds0bf6ubi7cf35l8jju